- Home
- WGSWW vs OCCIN Comparison
WGSWW vs OCCIN Comparison
Compare WGSWW & OCCIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- OCCIN
- Stock Information
- Founded
- WGSWW 2017
- OCCIN N/A
- Country
- WGSWW United States
- OCCIN United States
- Employees
- WGSWW 1000
- OCCIN N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- OCCIN Trusts Except Educational Religious and Charitable
- Sector
- WGSWW Technology
- OCCIN Finance
- Exchange
- WGSWW Nasdaq
- OCCIN Nasdaq
- Market Cap
- WGSWW N/A
- OCCIN N/A
- IPO Year
- WGSWW N/A
- OCCIN N/A
- Fundamental
- Price
- WGSWW $0.07
- OCCIN $24.40
- Analyst Decision
- WGSWW
- OCCIN
- Analyst Count
- WGSWW 0
- OCCIN 0
- Target Price
- WGSWW N/A
- OCCIN N/A
- AVG Volume (30 Days)
- WGSWW 36.6K
- OCCIN N/A
- Earning Date
- WGSWW 02-18-2025
- OCCIN N/A
- Dividend Yield
- WGSWW N/A
- OCCIN N/A
- EPS Growth
- WGSWW N/A
- OCCIN N/A
- EPS
- WGSWW N/A
- OCCIN N/A
- Revenue
- WGSWW $305,450,000.00
- OCCIN N/A
- Revenue This Year
- WGSWW N/A
- OCCIN N/A
- Revenue Next Year
- WGSWW N/A
- OCCIN N/A
- P/E Ratio
- WGSWW N/A
- OCCIN N/A
- Revenue Growth
- WGSWW 50.79
- OCCIN N/A
- 52 Week Low
- WGSWW $0.17
- OCCIN N/A
- 52 Week High
- WGSWW $0.21
- OCCIN N/A
- Technical
- Relative Strength Index (RSI)
- WGSWW 38.15
- OCCIN 49.54
- Support Level
- WGSWW $0.06
- OCCIN $24.36
- Resistance Level
- WGSWW $0.08
- OCCIN $24.42
- Average True Range (ATR)
- WGSWW 0.01
- OCCIN 0.09
- MACD
- WGSWW -0.00
- OCCIN -0.01
- Stochastic Oscillator
- WGSWW 5.80
- OCCIN 11.32
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
About OCCIN OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.